3 Recruiting Lupus Erythematosus, Systemic Phase 2 Clinical Trials

Active phase 2 studies for lupus erythematosus, systemic enrolling across the USA. Verify eligibility and contact site coordinators.

All Lupus Erythematosus, Systemic studies

Phase 2 Studies for Lupus Erythematosus, Systemic

🔵 Active, Not Recruiting Phase2

A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)

📍 Local Institution - 0106 — Phoenix, Arizona

View Study & Checklist ➔

🟢 Recruiting Phase2

A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

📍 University Of Alabama — Birmingham, Alabama

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

📍 Research Site — San Francisco, California

View Study & Checklist ➔